Fundz
Back to Investors

Track Sofinnova Partners's Investment Activity

Get real-time alerts when Sofinnova Partners makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.

Compare PlansProFull access from $49/mo
S

Sofinnova Partners

Venture Capital
sofinnovapartners.com
Total Deals
52
Recent (90d)
3
Total Capital
$3.4B
Co-Investors
252
They take pitches directly

Genuine open application. Their site has a dedicated "Submit a project" form asking for your details, company description, a project synopsis and a business plan (uploads capped at 5MB each), plus a choice of which fund strategy and funding stage you are applying to. They ask for a value proposition, a synopsis covering target market and size, competitive position, management team, development stage and financing needs, and a non-confidential presentation.

sofinnovapartners.com/submit

Worth knowing. The form makes you pick one of seven strategies, and they are not all checks into existing companies. MD Start is described as an "in-house medtech accelerator focused on creating and launching early-stage medtech companies through hands-on company building", and Biovelocita is a biotech accelerator that partners with research organisations "to create and build" startups. Sofinnova Capital, the flagship, says it invests "as founding or lead investor". Picking the wrong strategy routes you to the wrong team, and note the submission asks explicitly for a NON-confidential presentation.

How they invest
$50.4M
Median round they join
48
Companies backed
3
Checks in 90 days
Jun 22, 2026
Most recent check
Stages they write into
Series A 19Series B 11Funding Round 7Seed 6Series C 4

Built from 52 rounds we recorded since Dec 19, 2022.

Raising right now?

See every fund writing checks into companies like yours, ranked, each with a route in.

Build my investor list
B

Bionyra

Biotechnology
series a
$165.0M

Jun 22, 2026

B

Bionyra Pharma

BiotechnologyParis, France
series a
$165.0M

Jun 22, 2026

I

Ingenix

Biotechnology
seed
$14.1M

Jun 3, 2026

P

P2 Science

ManufacturingWoodbridge, United States
funding round
$23.0M

May 26, 2026

C

CellCentric

BiotechnologyCambridge, United Kingdom
series d
$220.0M

May 6, 2026

45+ more investments

View all 52 deals by Sofinnova Partners

ProFull deal history requires Pro

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity and website modifications, based on each user's watchlist and ICP. Trusted by firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz tracks 200,000+ companies and 40,000+ investors.

Fundz tracks 45,000 investors and their 13F holdings, alongside every round the companies they back raise.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.